(Q39945097)

English

The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Trypanosoma cruzi

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Antoniana Krettli

1

object named as

Antoniana Ursine Krettli

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

1 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Memórias do Instituto Oswaldo Cruz

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

104 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

142-151

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Proteomic analysis of Trypanosoma cruzi resistance to Benznidazole

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Chagas disease: what is known and what is needed--a background article

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusional Chagas disease. Historical aspects, present situation, and perspectives

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Chagas’ disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Soluble antigens released by Trypanosoma cruzi trypomastigotes used in ELISA to detect cure in chagasic patients following specific treatment

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

The targets of the lytic antibody response against Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

An update on Chagas disease (human American trypanosomiasis).

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Development and validation of a risk score for predicting death in Chagas' heart disease

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Trypanosoma cruzicell surface proteins: identification of one major glycoprotein

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900020

21 January 2018

Identifiers

10.1590/S0074-02762009000900020

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39945097&oldid=1879247488"